Product image of Linacon (Linagliptin) supplied by GNH India

Linacon

Active Ingredient:
Linagliptin
Origin:
EU

Linacon (Linagliptin)

Linagliptin, the active ingredient in Linacon, is a DPP-4 inhibitor presented as an oral tablet for oral use. It treats type 2 diabetes mellitus in adult patients.
GNH India supplies Linacon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Genericon Pharma Gesellschaft M.B.H.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linacon is a DPP-4 inhibitor indicated for the management of type 2 diabetes mellitus, helping to improve glycaemic control.

  • Type 2 diabetes mellitus: improves fasting and post‑prandial glucose levels as monotherapy.
  • Type 2 diabetes mellitus (combined therapy): enhances overall glucose management when used with other antidiabetic agents.
  • Type 2 diabetes mellitus (diet and exercise adjunct): supports target HbA1c achievement alongside lifestyle measures.

How It Works

  • Linagliptin selectively inhibits the enzyme dipeptidyl peptidase‑4 (DPP‑4), which results in increased levels of endogenous incretin hormones (GLP‑1 and GIP). Elevated incretins enhance glucose‑dependent insulin secretion and suppress glucagon release, thereby lowering blood glucose concentrations without causing hypoglycaemia in the absence of meals.

Side Effects

Adverse reactions to Linacon may vary in frequency and severity.

Common Side Effects

  • Nasopharyngitis: mild upper respiratory tract infection symptoms.
  • Headache: transient mild to moderate pain.
  • Upper respiratory infection: cough, sore throat, or congestion.
  • Dizziness: occasional light‑headedness.
  • Gastrointestinal discomfort: nausea, abdominal pain, or diarrhoea.

Serious or Rare Side Effects

  • Pancreatitis: severe abdominal pain requiring immediate medical attention.
  • Severe hypersensitivity: rash, angioedema, or anaphylaxis.
  • Hepatic injury: elevated liver enzymes or jaundice.
  • Bullous pemphigoid: blistering skin disorder.
  • Angioedema: swelling of face, lips, or throat.
  • Severe allergic reaction: systemic symptoms requiring emergency care.

Precautions & Warnings

When prescribing Linacon, clinicians should consider several safety aspects.

  • Renal impairment: monitor renal function, although dose adjustment is not required.
  • Hepatic impairment: assess liver enzymes and use with caution in severe disease.
  • Cardiovascular disease: observe for any cardiovascular events, especially in high‑risk patients.
  • Pregnancy: safety not established; avoid unless benefits outweigh risks.
  • Breastfeeding: unknown safety; consider discontinuation.
  • Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Linacon may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase linagliptin exposure.
  • Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce linagliptin exposure.
  • Co‑administration with another DPP‑4 inhibitor: duplicate therapy should be avoided.

Moderate Interactions (Monitor Closely)

  • Insulin or sulfonylureas: increased risk of hypoglycaemia; monitor glucose levels.
  • Moderate CYP3A4 inducers (e.g., phenobarbital): may lower efficacy.
  • Diuretics: may affect renal clearance; observe renal function.

Frequently Asked Questions

Linacon contains linagliptin, a DPP‑4 inhibitor indicated for the treatment of type 2 diabetes mellitus in adults. It helps lower blood glucose levels by enhancing insulin secretion and reducing glucagon release when combined with diet and exercise.

Linagliptin blocks the enzyme dipeptidyl peptidase‑4, which normally degrades incretin hormones. By preserving incretins such as GLP‑1 and GIP, the drug increases glucose‑dependent insulin release and suppresses glucagon, leading to improved glycaemic control without causing hypoglycaemia in the fasting state.

The prescribing healthcare professional determines the appropriate dose of Linacon based on the individual patient's clinical profile, renal and hepatic function, and concomitant therapies. Linagliptin is typically administered once daily, but the exact regimen is set by the prescriber.

Safety of linagliptin during pregnancy and lactation has not been established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To order Linacon, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Linacon (linagliptin) is distinguished by its primarily hepatic elimination, allowing use without dose adjustment in renal impairment, unlike many other DPP‑4 inhibitors that require renal dosing modifications. Efficacy and safety profiles are comparable across the class, but individual patient factors guide selection.

Linacon should be stored at ambient temperature, below 25 °C, in its original container to protect from moisture and light. Keep the product out of reach of children and avoid storing in bathrooms or other humid environments.

Linacon is taken orally as a tablet. Swallow the tablet whole with a glass of water, with or without food, once daily as directed by the prescribing clinician.

Serious adverse events include pancreatitis, severe hypersensitivity reactions such as angioedema or anaphylaxis, and hepatic injury. Patients should seek immediate medical attention if they experience persistent abdominal pain, rash with swelling, or signs of liver dysfunction.

Linacon is contraindicated in individuals with known hypersensitivity to linagliptin or any component of the formulation. Caution is also advised for patients with severe hepatic impairment, and it should be avoided in pregnancy and lactation unless clearly justified by a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linagliptin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT